This is a study of exon 51 skip-equivalent phenotypes from multiple registries. The study was limited in that no clinical information was available on 37 of the 48 possible skip-equivalents, which may be because these 37 variants are exceedingly rare or that the resulting clinical phenotypes are so mild that the mutations remain unreported.